|
Market Closed -
Nasdaq
16:00:00 2026-10-29 EDT
|
5-day change | 1st Jan Change | ||
| 21.48 USD | -1.24% |
|
+4.27% | -18.30% |
| 09-22 | Oppenheimer Adjusts Price Target on Tyra Bioscience to $40 From $50, Keeps Outperform Rating | MT |
| 09-14 | Tyra Bioscience Shares Rise After Pricing $400 Million Offering | MT |
Company Valuation: Tyra Biosciences, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 571.9 | 317.9 | 596.3 | 731.2 | 1,403 | 1,495 | - | - |
| Change | - | -44.42% | 87.61% | 22.61% | 91.9% | 6.58% | - | - |
| Enterprise Value (EV) 1 | 571.9 | 317.9 | 596.3 | 389.7 | 1,147 | 1,005 | 1,173 | 1,495 |
| Change | - | -44.42% | 87.61% | -34.64% | 194.33% | -12.41% | 16.69% | 27.54% |
| P/E | -7.37x | -5.76x | -8.55x | -9.21x | -13.1x | -8.18x | -7.84x | -6.84x |
| PBR | - | - | - | 2.06x | - | - | - | - |
| PEG | - | 0.2x | -0.4x | 1.36x | -0.4x | -0.3x | -1.81x | -0.5x |
| Capitalization / Revenue | - | - | - | - | - | - | - | 1,006x |
| EV / Revenue | - | - | - | - | - | - | - | 1,006x |
| EV / EBITDA | -21.9x | -5.42x | -7.49x | -3.76x | -8.68x | -5.03x | -5.54x | - |
| EV / EBIT | -21.8x | -5.39x | -7.46x | -3.74x | -8.64x | -5.28x | -5.27x | -5.84x |
| EV / FCF | -23.4x | -6.25x | -11.7x | -5.64x | -12x | -14.5x | -14.6x | -374x |
| FCF Yield | -4.27% | -16% | -8.54% | -17.7% | -8.31% | -6.92% | -6.87% | -0.27% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | -1.91 | -1.32 | -1.62 | -1.51 | -2.01 | -2.659 | -2.774 | -3.179 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | - | - | - | - | - | - | - | 1.486 |
| EBITDA 1 | -26.15 | -58.63 | -79.59 | -103.7 | -132.2 | -199.7 | -211.7 | - |
| EBIT 1 | -26.29 | -58.93 | -79.94 | -104.2 | -132.8 | -190.4 | -222.4 | -255.9 |
| Net income 1 | -26.29 | -55.32 | -69.13 | -86.48 | -119.9 | -177.4 | -209.2 | -245.1 |
| Net Debt 1 | - | - | - | -341.4 | -256 | -490.6 | -322.9 | - |
| Reference price 2 | 14.07 | 7.60 | 13.85 | 13.90 | 26.29 | 21.75 | 21.75 | 21.75 |
| Nbr of stocks (in thousands) | 40,647 | 41,825 | 43,057 | 52,603 | 53,372 | 68,756 | - | - |
| Announcement Date | 3/3/22 | 3/22/23 | 3/19/24 | 3/27/25 | 3/2/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -8.18x | - | -5.03x | -.--% | 1.5B | |
| 16.92x | 6.39x | 12.26x | 1.77% | 64.14B | |
| 30.57x | 8.11x | 26.59x | 0.05% | 55.53B | |
| 36.68x | 6.52x | 19.45x | 0.88% | 53.03B | |
| 35.39x | 3.41x | 14.74x | -.--% | 45.99B | |
| 49.25x | 5.68x | 31.09x | -.--% | 42.45B | |
| -19.59x | 189.6x | -20.86x | -.--% | 40.45B | |
| 31.7x | 8.06x | 20.96x | 0.41% | 32.25B | |
| 47.12x | 8.37x | 28.08x | -.--% | 34.47B | |
| 27.96x | 5.9x | 15.29x | -.--% | 24.23B | |
| Average | 24.78x | 26.89x | 14.26x | 0.31% | 39.4B | |
| Weighted average by Cap. | 27.83x | 25.38x | 16.38x | 0.45% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- TYRA Stock
- Valuation Tyra Biosciences, Inc.
Select your edition
All financial news and data tailored to specific country editions
